Report Description

India tomato fever therapeutics market may register growth during the forecast period, 2024-2028, on the backbone of increasing instances of the disease among the population of the country. Sudden increase in the cases along with the demand for the symptomatic control over the diseases and related pharmaceutical drives the growth of the India tomato fever therapeutics market in the upcoming five years. Increasing threat of infectious diseases and recent outbreak of the COVID-19 and causing pandemic is also influencing the population to look for the effective drugs and therapeutics to control the infection also supports the growth of the India tomato fever therapeutics market in the next five years.

Growing Instances Drive Market Growth

Rapidly increasing instances of tomato fever is the major factor driving the growth of the India tomato fever therapeutics market in the upcoming five years. Surge in the number of cases is majorly from the southern region of the country. States like Tamil Nadu, Karnataka, and Andhra Pradesh are at high alert against the diseases. Precautionary steps are taken to modulate the increasing cases. Every person crossing the borders with Kerala is being tested to identify the potent carriers of the infection and infected to control the spread of infection in rest of the country.

The infection emerges from the Shigella bacterium and is often transferred through food or unhygienic water. Although complete causes for the infectious diseases are not yet determined. Cities like Kollam, Neduvathur, Anchal, Aryankavu in the state of Kerala have by far shown significant increase in the number of cases. Government run food and childcare center, Anganwadi centers have been temporarily restricted from functioning. The step is to control further increase of the tomato fever cases. The disease is widespread among the children younger than 5 year old.

Demands For Symptomatic Relief Fuels Market Growth

Tomato fever is a comparatively new infection and the medicines to control the infection of to cure the disease have not yet been formularized. Before commercializing the medicines and other therapeutics specific for the disease, the approvals and clinical trials would take long time. In such circumstances, the demand for the symptomatic relief increases and thus aids the growth of the India tomato fever therapeutics market in the future five years. The symptoms include tomato sized rashes (thus the name of the diseases), along with skin irritation, dehydration to the patient, and in certain cases, worms from the boils have also been reported.

Surging demands for the anti-inflammatory drugs, and pain relievers are actively driving the growth of the India tomato fever therapeutics market in the next five years. Symptomatic control is necessary for the relief of the patient, moreover, the experts announce that the infection is currently self-limiting, and the symptoms usually resolve with time and care. Maintenance of the hygienic conditions like sanitizing the personal belongings maintaining distance with the infected and not using the stuff without sanitization would help in controlling the spread of the infection among other population.


Click here to download the sample

Market Segmentation

The India tomato fever therapeutics market segmentation is based on drug type, route of administration, distribution channel, regional distribution, and competitional landscape. Based on drug type, the market is further segmented into pain relievers, non-steroidal anti-inflammatory drugs, and nucleoside analogue antivirals. By route of administration, topical, oral, and intravenous. Based on distribution channel, the market is bifurcated into hospital pharmacies, retail pharmacies, and online pharmacies. The India tomato fever therapeutics market analysis also studies the regional segmentation divided among North India region, South India region, East India region, and West India region. Each region in the country is further analyzed for the top 3 states of the market.

Company Profile

Johnson & Johnson India Limited, GlaxoSmithKline Pharmaceuticals Ltd., Takeda Pharmaceuticals India Pvt. Ltd., Emergex Vaccines Holding Ltd., CJ HealthCare Corp., are some of the major market players in the country that lead the market growth analysis.

Attribute

Details

Base Year

2022

Historic Data

2018 – 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018 – 2021 and 2024 – 2028

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Drug Type

·         Route of Administration

·         Distribution Channel

Regional scope

North; South; East; West;

Key companies profiled

Johnson & Johnson India Limited, GlaxoSmithKline Pharmaceuticals Ltd., Takeda Pharmaceuticals India Pvt. Ltd., Emergex Vaccines Holding Ltd., CJ HealthCare Corp.

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, India tomato fever therapeutics market is segmented into following categories, in addition to the industry trends which have also been detailed below:

·         India Tomato Fever Therapeutics Market, By Drug Type:

o   Pain Relievers

o   Non-Steroidal Anti-inflammatory Drugs

o   Nucleoside Analogue Antivirals

  • India Tomato Fever Therapeutics Market, By Route of Administration:

o   Topical

o   Oral

o   Intravenous

  • India Tomato Fever Therapeutics Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • India Tomato Fever Therapeutics Market, By Region:
    • South
    • West
    • North
    • East

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India tomato fever therapeutics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

India Tomato Fever Therapeutics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.     Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on India Tomato Fever Therapeutics Market

4.    Executive Summary

5.    Voice of Customers

6.    India Tomato Fever Therapeutics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Type (Pain Relievers, Non-Steroidal Anti-inflammatory Drugs, Nucleoside Analogue Antivirals)

6.2.2.     By Route of Administration (Topical, Oral, Intravenous)

6.2.3.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

6.2.4.     By Region

6.2.4.1.         By State (Top 3 States)

6.2.5.     By Company (2022)

6.3.  Product Market Map

7.    South India Tomato Fever Therapeutics Market Outlook

7.1.  Market Size & Forecast

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Drug Type

7.2.2.     By Route of Administration

7.2.3.     By Distribution Channel

8.    West India Tomato Fever Therapeutics Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Drug Type

8.2.2.     By Route of Administration

8.2.3.     By Distribution Channel

9.    North India Tomato Fever Therapeutics Market Outlook

9.1.  Market Size & Forecast

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Drug Type

9.2.2.     By Route of Administration

9.2.3.     By Distribution Channel

10.  East India Tomato Fever Therapeutics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Drug Type

10.2.2.  By Route of Administration

10.2.3.  By Distribution Channel

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Policy & Regulatory Landscape

14.  India Economic Profile

15.  Competitive Landscape

15.1.              Johnson & Johnson India Limited

15.2.              GlaxoSmithKline Pharmaceuticals Ltd

15.3.              Takeda Pharmaceuticals India Pvt. Ltd

15.4.              Emergex Vaccines Holding Ltd

15.5.              CJ HealthCare Corp.

16.  Strategic Recommendations

(Note: The companies list can be customized based on the client requirements.)

Note: The data given for any year represents the market during the period, i.e., 1st April of the previous year to 31st March of that year. Ex: For 2023E, the data represents the period, 1st April 2022 to 31st March 2023. Please note that all the macro-economic indicators in the economic profiles are for Calendar year.

Figures and Tables

Frequently asked questions

down-arrow

India tomato fever therapeutics market is anticipated to grow with an impressive CAGR during the forecast period on account of advancing pharmaceutical sector in the country.

down-arrow

New market players may invest actively in research and innovative product development. Also, advancing their existent technology according to evolving consumer preferences along with merger and acquisitions with the global giants can be viable strategic recommendations for the future brand establishments.

down-arrow

Johnson & Johnson India Limited, GlaxoSmithKline Pharmaceuticals Ltd., Takeda Pharmaceuticals India Pvt. Ltd., Emergex Vaccines Holding Ltd., CJ HealthCare Corp., among others form a partial list of the market players that may dominate the future India tomato fever therapeutics market with their innovative product line.

down-arrow

Due to the recent outbreak of viral COVID-19 infection, the government as well as the population is at high alert for the spreading infections. In their reports, the authorities include the multiple versions of the coronavirus and are actively trying to approve the therapeutics applicable as a treatment for the tomato fever therapeutics.

profile

Sakshi Bajaal

Business Consultant
Press Release

India Tomato Fever Therapeutics Market To Grow With Surging Disease Instances

May, 2022

Evolving pharmaceutical advances promises growth for the India Tomato Fever Therapeutics Market during 2024-2028F.